Grimes & Company Inc. Has $855,000 Stake in Danaher Co. (DHR)

Grimes & Company Inc. trimmed its position in Danaher Co. (NYSE:DHR) by 8.2% in the first quarter, Holdings Channel reports. The institutional investor owned 6,480 shares of the conglomerate’s stock after selling 579 shares during the period. Grimes & Company Inc.’s holdings in Danaher were worth $855,000 as of its most recent filing with the Securities and Exchange Commission.

Other institutional investors have also recently modified their holdings of the company. Lenox Wealth Management Inc. bought a new position in Danaher during the first quarter worth $40,000. Hall Laurie J Trustee increased its holdings in Danaher by 1.6% in the 1st quarter. Hall Laurie J Trustee now owns 25,266 shares of the conglomerate’s stock valued at $3,337,000 after buying an additional 401 shares during the period. Pinnacle Financial Partners Inc. increased its holdings in Danaher by 5.6% in the 1st quarter. Pinnacle Financial Partners Inc. now owns 34,867 shares of the conglomerate’s stock valued at $4,603,000 after buying an additional 1,853 shares during the period. State of New Jersey Common Pension Fund D increased its holdings in Danaher by 87.5% in the 1st quarter. State of New Jersey Common Pension Fund D now owns 300,000 shares of the conglomerate’s stock valued at $39,606,000 after buying an additional 140,000 shares during the period. Finally, Savant Capital LLC increased its holdings in Danaher by 6.3% in the 1st quarter. Savant Capital LLC now owns 4,718 shares of the conglomerate’s stock valued at $623,000 after buying an additional 278 shares during the period. Institutional investors and hedge funds own 76.98% of the company’s stock.

Several brokerages have issued reports on DHR. Zacks Investment Research raised shares of Danaher from a “sell” rating to a “hold” rating in a report on Monday, May 6th. Needham & Company LLC reiterated a “buy” rating and set a $141.00 price target (up previously from $138.00) on shares of Danaher in a research report on Wednesday, April 17th. JPMorgan Chase & Co. reiterated an “overweight” rating and set a $140.00 price target on shares of Danaher in a research report on Monday, March 4th. Janney Montgomery Scott upped their target price on shares of Danaher from $136.00 to $174.00 and gave the company a “buy” rating in a research report on Wednesday, April 17th. Finally, Jefferies Financial Group upped their target price on shares of Danaher to $140.00 and gave the company a “buy” rating in a research report on Tuesday, February 26th. Two analysts have rated the stock with a hold rating and eleven have assigned a buy rating to the company’s stock. The stock presently has a consensus rating of “Buy” and an average price target of $131.75.



In other Danaher news, Chairman Mitchell P. Rales purchased 1,900 shares of the firm’s stock in a transaction dated Friday, May 10th. The stock was bought at an average cost of $130.78 per share, with a total value of $248,482.00. The acquisition was disclosed in a document filed with the SEC, which can be accessed through this link. Also, CAO Robert S. Lutz sold 15,000 shares of the firm’s stock in a transaction that occurred on Sunday, February 24th. The stock was sold at an average price of $127.00, for a total transaction of $1,905,000.00. Following the transaction, the chief accounting officer now directly owns 22,251 shares of the company’s stock, valued at $2,825,877. The disclosure for this sale can be found here. Insiders have sold a total of 424,761 shares of company stock valued at $54,983,097 over the last ninety days. Company insiders own 11.40% of the company’s stock.

Shares of DHR stock opened at $130.75 on Thursday. Danaher Co. has a one year low of $94.59 and a one year high of $134.67. The company has a debt-to-equity ratio of 0.32, a current ratio of 2.18 and a quick ratio of 1.74. The stock has a market capitalization of $92.68 billion, a PE ratio of 28.93, a P/E/G ratio of 2.50 and a beta of 1.02.

Danaher (NYSE:DHR) last issued its quarterly earnings results on Thursday, April 18th. The conglomerate reported $1.07 earnings per share for the quarter, topping the consensus estimate of $1.01 by $0.06. The company had revenue of $4.88 billion during the quarter, compared to analysts’ expectations of $4.80 billion. Danaher had a net margin of 12.04% and a return on equity of 11.61%. The business’s quarterly revenue was up 3.9% on a year-over-year basis. During the same period last year, the business earned $0.99 EPS. As a group, sell-side analysts expect that Danaher Co. will post 4.77 earnings per share for the current fiscal year.

The firm also recently declared a quarterly dividend, which will be paid on Friday, July 26th. Stockholders of record on Friday, June 28th will be paid a dividend of $0.17 per share. The ex-dividend date of this dividend is Thursday, June 27th. This represents a $0.68 annualized dividend and a dividend yield of 0.52%. Danaher’s dividend payout ratio is currently 15.04%.

COPYRIGHT VIOLATION WARNING: “Grimes & Company Inc. Has $855,000 Stake in Danaher Co. (DHR)” was originally reported by Dakota Financial News and is the sole property of of Dakota Financial News. If you are reading this article on another site, it was copied illegally and republished in violation of international trademark & copyright law. The original version of this article can be accessed at https://dakotafinancialnews.com/2019/05/16/grimes-company-inc-has-855000-stake-in-danaher-co-dhr.html.

Danaher Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company's Life Sciences segment provides mass spectrometers; cellular analysis, lab automation, and centrifugation instruments; microscopes; and genomics consumables.

Featured Story: Why Invest in Dividend Achievers?

Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Co. (NYSE:DHR).

Institutional Ownership by Quarter for Danaher (NYSE:DHR)

Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.